Full-Time

Director – Statistical Programming

Posted on 4/10/2024

Cytokinetics

Cytokinetics

201-500 employees

Develops muscle function drugs for diseases

Biotechnology

Senior

San Bruno, CA, USA

Requirements
  • Bachelor’s degree in statistics, computer science, mathematics, or related fields
  • 12+ years of biopharmaceutical experience as a Statistical Programmer
  • 5+ years of supervisory experience
  • Extensive knowledge of SAS programming concepts and skills
  • Thorough understanding of CDISC SDTM and ADaM standards
  • Experience leading integrations (ISE/ISS) and regulatory submissions
  • Experience contributing to departmental budget and resource planning
  • Proficiency in communicating complex ideas to varied audiences
  • Strong leadership skills and teamwork spirit
  • Ability to manage multiple projects and deadlines in a fast-paced environment
Responsibilities
  • Lead statistical programming activities for one or multiple compounds
  • Lead process improvement initiatives across Biometrics
  • Provide technical leadership and support for an indication/disease area
  • Assist in implementing Statistical Programming strategies
  • Review and comment on study-related documents
  • Participate in statistical analysis plans and TFL specifications
  • Contribute to company SOPs and guidance documents
  • Keep abreast of advancements in SAS

Cytokinetics is a late-stage biopharmaceutical company focused on developing small molecule muscle activators and inhibitors to address impaired muscle function in conditions such as heart failure, hypertrophic cardiomyopathy, and neuromuscular diseases. The company's main technologies involve engineering drug candidates to impact muscle function and contractility, with the goal of discovering, developing, and commercializing potential treatments for debilitating diseases.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

South San Francisco, California

Founded

1998

Growth & Insights
Headcount

6 month growth

0%

1 year growth

4%

2 year growth

33%
INACTIVE